Qinglong Guo

13.2k total citations · 1 hit paper
330 papers, 11.0k citations indexed

About

Qinglong Guo is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, Qinglong Guo has authored 330 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Molecular Biology, 130 papers in Pharmacology and 69 papers in Plant Science. Recurrent topics in Qinglong Guo's work include Flavonoids in Medical Research (78 papers), Natural Compound Pharmacology Studies (54 papers) and Synthesis of Organic Compounds (44 papers). Qinglong Guo is often cited by papers focused on Flavonoids in Medical Research (78 papers), Natural Compound Pharmacology Studies (54 papers) and Synthesis of Organic Compounds (44 papers). Qinglong Guo collaborates with scholars based in China, United States and Taiwan. Qinglong Guo's co-authors include Qidong You, Na Lu, Li Zhao, Zhiyu Li, Qi Qi, Yong Yang, Hong-Yan Gu, Libin Wei, Xiaotang Wang and Yun Ling and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Qinglong Guo

327 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma

2021 155 citations Qinglong Guo, Yuening Sun et al. profile →

Peers

Countries citing papers authored by Qinglong Guo

Since Specialization

Citations

This map shows the geographic impact of Qinglong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglong Guo more than expected).

Fields of papers citing papers by Qinglong Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglong Guo. The network helps show where Qinglong Guo may publish in the future.

Co-authorship network of co-authors of Qinglong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglong Guo. A scholar is included among the top collaborators of Qinglong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglong Guo. Qinglong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LW-213, a derivative of wogonin, triggers reticulophagy-mediated cell death in NSCLC via lysosomal damage combined with NPC1 inhibition 2024 ·Phytomedicine ·Hongzheng Wang, Yuexin Jiang, Mengyuan Zhu, Hui Li, Hongyu Chen, Haidi Wang, Shuai Zhang, Qinglong Guo, Hui Hui	3
2	Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance 2024 ·Chinese Medicine ·Hongzheng Wang, Min Huang, (unknown), (unknown), Yijian Zhang, Hongyu Chen, Yuexin Jiang, Haidi Wang, Qinglong Guo, Shuai Zhang	4
3	AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations 2023 ·Cancer Letters ·(unknown), Xuefeng Zhang, Ruitian Zhang, Yuening Sun, Jian Liu, (unknown), (unknown), Weiming Fang, Qinglong Guo, Libin Wei	14
4	Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies 2023 ·Clinical and Translational Medicine ·(unknown), Yongjian Guo, (unknown), Po Hu, Hui Li, Xiaoxuan Yu, (unknown), Hongzheng Wang, Zhanyu Wang, Jingyan Xu, Qinglong Guo, Hui Hui	7
5	AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma 2022 ·Oncogene ·Di Pan, (unknown), (unknown), (unknown), (unknown), (unknown), Xiangshan Fan, (unknown), (unknown), Haopeng Sun, (unknown), (unknown), (unknown), Qinglong Guo, Li Zhao	19
6	One‐Two Punch Therapy for the Treatment of T‐Cell Malignancies Involving p53‐Dependent Cellular Senescence 2021 ·Oxidative Medicine and Cellular Longevity ·(unknown), Hui Li, (unknown), Po Hu, Xiangyuan Wang, Xiaoxuan Yu, (unknown), Hongzheng Wang, Zhanyu Wang, Qinglong Guo, Hui Hui	10
7	Involvement of p53 Acetylation in Growth Suppression of Cutaneous T-Cell Lymphomas Induced by HDAC Inhibition 2020 ·Journal of Investigative Dermatology ·Xiaoxuan Yu, Hui Li, (unknown), Po Hu, (unknown), (unknown), Xiangyuan Wang, Hongzheng Wang, Zhanyu Wang, Jingyan Xu, Renxiang Tan, Qinglong Guo, Hui Hui	22
8	Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription 2020 ·Oncogene ·(unknown), (unknown), Wenshu Li, (unknown), (unknown), Mengyuan Li, Yuan He, Xiaosheng Wang, Qinglong Guo, Li Zhao, Lei Qiang	40
9	YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity 2019 ·Proceedings of the National Academy of Sciences ·Lirui Wang, Magdalena Mazagova, Chuyue Pan, Song Yang, Katharina Brandl, Jun Liu, Shannon M. Reilly, Yanhan Wang, (unknown), Rohit Loomba, Na Lu, Qinglong Guo, Jihua Liu, Ruth T. Yu, Michael Downes, Ronald M. Evans, David A. Brenner, Alan R. Saltiel, Bruce Beutler, Bernd Schnabl	29
10	Oroxylin A inhibits invasion and migration through suppressing ERK/GSK‐3β signaling in snail‐expressing non‐small‐cell lung cancer cells 2016 ·Molecular Carcinogenesis ·Libin Wei, Yuyuan Yao, Kai Zhao, Yujie Huang, Yuxin Zhou, Li Zhao, Qinglong Guo, Na Lu	32
11	Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β‐catenin pathway 2015 ·Molecular Carcinogenesis ·Yujie Huang, Kai Zhao, Yang Hu, Yuxin Zhou, (unknown), Xiaorui Li, Libin Wei, Zhiyu Li, Qidong You, Qinglong Guo, Na Lu	42
12	Screening and Identification of Mycobacterium tuberculosis Biofilm Formation Related Genes 2013 ·Zhongguo shengwu gongcheng zazhi ·Xia Liu, Qinglong Guo, (unknown), Honghai Wang, Xiuying Pei, Xuelian Zhang	1
13	Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells 2013 ·The International Journal of Biochemistry & Cell Biology ·Qinsheng Dai, (unknown), Wei Liu, Libin Wei, Yuxin Zhou, Zhiyu Li, Qidong You, Na Lu, Qinglong Guo	33
14	Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein 2013 ·Toxicology and Applied Pharmacology ·Xiuming Song, Jing Yao, Fei Wang, Mi Zhou, Yuxin Zhou, Hu Wang, Libin Wei, Li Zhao, Zhiyu Li, Na Lu, Qinglong Guo	66
15	Advances in Application of Interleukin-2 and Its Related Drugs 2011 ·Qinglong Guo	1
16	Research advances in wogonin′s anti-tumor effects 2009 ·Zhongguo yaoke daxue xuebao ·Yang Li, Qidong You, Yang Yong, Qinglong Guo	1
17	Effects of a Compound Extract from Agrimonia pilosa Ledeb, Grifola umbellata (pers.) Pilat, and Gambogia on Human Gastric Carcinoma MGC-803 Cells 2009 ·Food Science and Biotechnology ·Li Zhao, Xiaonan Zhang, (unknown), Jia Wang, Tao Lei, Rong Mu, Qinglong Guo	4
18	Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Zhiyu Li, (unknown), Li Zhao, Qinglong Guo, Qidong You	8
19	Study of YCP on the Reducing Toxicity of the Radiochemotherapy and Promotion on the Immune System 2005 ·Pharmaceutical biotechnology ·Qinglong Guo, Xiangdong Gao, Jing Xu	2
20	Effect of marine fungous polysaccharide YCP on tumor growth and immune function of tumor-bearing mice 1994 ·Zhongcaoyao ·Zhen Chen, (unknown), Qinglong Guo, Shengtao Yuan, Xiangdong Gao	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact